English
Home > Products > Intedanib advance intermediate

China Intedanib advance intermediate Factory

We also offer you product sourcing and flight consolidation expert services. We've our personal manufacturing unit and sourcing business. We can offer you virtually every variety of merchandise associated to our item range for Intedanib advance intermediate,CAS NO 6099-90-7,6099-90-7,Intedanib intermediate,Phloroglucinol dihydrate, We warmly welcome good friends from all walks of life to cooperate with us.
Intedanib advance intermediate, Many kinds of different goods are available for you to choose, you can do one-stop shopping here. And customized orders are acceptable. Real business is to get win-win situation, if possible, we would like to provide more support for customers. Welcome all nice buyers communicate details of products with us!!

Related Products

Hot Products

  • 1-(3-Methoxypropyl)-4-piperidinamine

    1-(3-Methoxypropyl)-4-piperidinamine

    Product Name:1-(3-Methoxypropyl)-4-piperidinamine
    Molecular Formula:C9H20N2O
    Molecular Weight:172.27
    CAS Registry Number:179474-79-4
  • Butyl chloroformate

    Butyl chloroformate

    Product Name:Butyl chloroformate
    Molecular Formula:C5H9ClO2
    Molecular Weight:136.58
    CAS Registry Number;592-34-7
  • POLYDIMETHYLSILOXANE

    POLYDIMETHYLSILOXANE

    Product Name:POLYDIMETHYLSILOXANE
    Molecular Formula:(C2H6OSi)n
    CAS Registry Number;8050-81-5
  • 4-vinyl-2，3-dihydrobenzofurane

    4-vinyl-2，3-dihydrobenzofurane

    Product Name:4-vinyl-2，3-dihydrobenzofurane
    Molecular Formula:C10H10O
    Molecular Weight:146.19
    CAS Registry Number:230642-84-9
  • Propyl chloroformate

    Propyl chloroformate

    Product Name:Propyl chloroformate
    Molecular Formula:C4H7ClO2
    Molecular Weight:122.55
    CAS Registry Number;109-61-5
  • Dapsone

    Dapsone

    Product Name:Dapsone
    Molecular Formula:C12H12N2O2S
    Molecular Weight;248.3
    CAS Registry Number;80-08-0
  • Related Blog
  • Reviews

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

  • Differences Between Pharmaceutical Raw Materials, Excipients and Pharmaceutical Intermediates

    In the pharmaceutical industry, there are various names of raw materials, such as pharmaceutical raw materials, pharmaceutical intermediates and pharmaceutical excipients in the process of pharmaceutical production. This article will take everyone to recognize these three concepts.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept